Company profile for Quris

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Quris is an artificial intelligence innovator that is disrupting drug development. Its machine-learning bio-platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials. Quris is led by a track-record team of top scientists and strategic investors. Its first AI-based drug is now prepping for clinical testing.We are led by a team of top scientists and strategic i...
Quris is an artificial intelligence innovator that is disrupting drug development. Its machine-learning bio-platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials. Quris is led by a track-record team of top scientists and strategic investors. Its first AI-based drug is now prepping for clinical testing.We are led by a team of top scientists and strategic investors and are actively preparing for clinical testing with our first AI-based drug.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
114 Yigal Alon st., Tel-Aviv
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/01/07/3005473/0/en/Quris-AI-s-Bio-AI-Platform-Integrated-by-Merck-KGaA-Darmstadt-Germany-for-Preclinical-Small-Molecule-Drug-Safety-Evaluation.html

GLOBENEWSWIRE
07 Jan 2025
Quris-AI Acquires Nortis
Quris-AI Acquires Nortis

29 Oct 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/10/29/2970665/0/en/Quris-AI-Acquires-Nortis.html

GLOBENEWSWIRE
29 Oct 2024

https://www.globenewswire.com//news-release/2024/01/04/2803916/0/en/Former-Biogen-CEO-Michel-Vounatsos-Joins-Quris-AI-Board.html

GLOBENEWSWIRE
04 Jan 2024

https://www.globenewswire.com//news-release/2023/09/28/2751130/0/en/Merck-KGaA-Darmstadt-Germany-and-Quris-AI-Expand-Collaboration.html

GLOBENEWSWIRE
28 Sep 2023

https://www.globenewswire.com/news-release/2023/01/18/2590734/0/en/Quris-AI-and-MBZUAI-to-launch-world-class-Bio-AI-center-in-Abu-Dhabi.html

GLOBENEWSWIRE
18 Jan 2023
Quris reels in $9M in funding to support innovations in trials
Quris reels in $9M in funding to support innovations in trials

21 Dec 2022

// Joseph Keenan FIERCEBIOTECH

https://www.fiercebiotech.com/cro/quris-reels-9m-seed-funding-support-ai-innovations-trials

Joseph Keenan FIERCEBIOTECH
21 Dec 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty